Abstract
FTY720 is a novel immunomodulating drug that can be phosphorylated inside cells; its phosphorylated form, FTY720-P, binds to a sphingosine 1-phosphate (S1P) receptor, S1P(1), and inhibits lymphocyte egress into the circulating blood. Although the importance of its pharmacological action has been well recognized, little is known about how FTY720-P is released from cells after its phosphorylation inside cells. Previously, we showed that zebrafish Spns2 can act as an S1P exporter from cells and is essential for zebrafish heart formation. Here, we demonstrate that human SPNS2 can transport several S1P analogues, including FTY720-P. Moreover, FTY720-P is transported by SPNS2 through the same pathway as S1P. This is the first identification of an FTY720-P transporter in cells; this finding is important for understanding FTY720 metabolism.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Biological Transport / drug effects
-
Biological Transport / physiology
-
CHO Cells
-
Carrier Proteins / genetics
-
Carrier Proteins / metabolism*
-
Cricetinae
-
Cricetulus
-
Fingolimod Hydrochloride
-
Humans
-
Immunosuppressive Agents / pharmacokinetics
-
Immunosuppressive Agents / pharmacology*
-
Lysophospholipids / genetics
-
Lysophospholipids / metabolism
-
Membrane Proteins / genetics
-
Membrane Proteins / metabolism*
-
Mice
-
Phosphorylation / drug effects
-
Phosphorylation / physiology
-
Propylene Glycols / pharmacokinetics
-
Propylene Glycols / pharmacology*
-
Receptors, Lysosphingolipid / genetics
-
Receptors, Lysosphingolipid / metabolism
-
Sphingosine / analogs & derivatives*
-
Sphingosine / genetics
-
Sphingosine / metabolism
-
Sphingosine / pharmacokinetics
-
Sphingosine / pharmacology
Substances
-
Carrier Proteins
-
Immunosuppressive Agents
-
Lysophospholipids
-
Membrane Proteins
-
Propylene Glycols
-
Receptors, Lysosphingolipid
-
sphingosine 1-phosphate
-
Fingolimod Hydrochloride
-
Sphingosine